Scientists at a U.S. Army research center have modified an assay that tests whether or not a sample of mosquitoes harbors the virus responsible for the disease known as chikungunya (CHIKV), long a problem in the Old World tropics but recently established in the Americas.
They did not make the assay — a commercial company called VecTOR Test Systems, Inc. did. Instead, the Army researchers tested the test to prove that it works — no small task when dealing with a virus that comes in multiple guises. Their assay is described in an article in the Journal of Medical Entomology.
Health workers now have what the scientists call a “quick and dirty” way to detect the presence of the CHIKV virus within an hour, rather than waiting for results of laboratory tests that take days, even weeks. It’s done with a chemical dipstick, the same kind of simple tool used in a pregnancy test. If the test is positive, measures to control and contain the disease can be mobilized and started immediately, which is important because no vaccine or specific treatment for chikungunya exists.
Evaluation was carried out under epidemiologist Michael J. Turell, PhD, a principal investigator for 30 years at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland. Turell’s research has focused on factors impacting the ability of mosquitoes to transmit various arboviruses, a term for viruses transmitted by arthropods such as mosquitoes, sandflies, and ticks. In addition, he has worked on the development of vaccines for several mosquito-borne viruses and on assays that detect arboviruses.
The larvae of mosquitoes that transmit CHIKV find excellent harborage in containers that hold standing water, such as spare tires, empty pails, and saucers under flower pots. Thus, the mosquitoes involved prosper among high concentrations of people. People living in tropical shanty towns, with open windows and no air conditioning, are prime targets.
“Chikungunya” is a term used by people of the Makonde Plateau, between Tanzania and Mozambique, where the disease was discovered in 1952. It means, “that which bends up,” referring to the way arthritis caused by the disease crooks posture of the victim’s body. Symptoms of chikungunya can be as brutal as its name is to pronounce, although it is seldom fatal. Victims experience fever and pain and swelling of muscles and joints. Headache and rash may occur. The disabling impact can last for months.
The chikungunya virus belongs to a group known as alphaviruses, at least 30 of which can infect humans and other vertebrates, causing diseases such as equine encephalitis and a variety of rash-accompanied fevers. CHIKV is transmitted by mosquitoes of the genus Aedes, chiefly Aedes aegypti, the bane of humans in the tropics because it also carries viruses responsible for yellow fever and dengue fever. Scientists have identified three different lineages — genetically-related groups — of CHIKV linked to geographical areas: Asia, West Africa, and East/Central/South Africa. All of the lineages exist outside the geographical areas after which they are named. A member of the Asian lineage, for example, has infected people in the Americas.
Like many tropical diseases, chikungunya has been rampant in the developing world for many years, but only became the focus of intensive research after it threatened western nations. An outbreak on Reunion Island, a French Department in the Indian Ocean, during 2005 and 2006 attracted attention largely because it’s a hot tourist destination for Europeans. Perhaps not by coincidence, the first transmission from mosquitoes in the Americans occurred in December 2013, on the French half of St. Martin, and island in the Caribbean. Reported cases in the Americas have now passed 1.5 million.
It began to show up in the United States during 2014, with nearly 2,500 cases reported from 46 states. Nearly all, however, were in travelers who picked up the infection in the tropics. Eleven people on the U.S. mainland, all in South Florida, contracted the disease directly from mosquitoes in the U.S.
The Latest on: Chikungunya
via Google News
The Latest on: Chikungunya
- At 659 cases, Pune accounts for 60% of chikungunya burden in stateon November 19, 2019 at 9:59 pm
PUNE: Extended rainfall, flooding and large-scale construction ensured that Pune (city and rural parts) retained its dubious distinction of recording most chikungunya cases in the state this year too.
- Chikungunya Fever Drugs Market A Comprehensive study with Leading Players| Abivax, Arno Therapeutics, Bharat Biotechon November 19, 2019 at 9:31 am
Nov 19, 2019 (HTF Market Intelligence via COMTEX) -- The definitive source for facts, data and analysis of the Global Chikungunya Fever Drugs market. Check Sample Pages of Global Chikungunya Fever ...
- Ethiopia chikungunya update: Nearly 2,000 additional cases reportedon November 18, 2019 at 5:53 pm
In a follow-up on the chikungunya outbreak in Ethiopia, nearly 2,000 additional suspected cases have been reported in recent weeks, bringing the outbreak total from Dire Dawa City Administrative ...
- Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Planson November 18, 2019 at 4:27 pm
Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans Final Phase 1 results up to Month 13 confirm the excellent immunogenicity and safety profile for ...
- Sterilizing mosquitoes may be the answer to curb Zika, Dengue, Chikungunya, WHO reportson November 18, 2019 at 2:18 pm
A new technique that sterilizes male mosquito through radiation shows promise in fighting mosquito-borne illnesses, including Zika, dengue and chikungunya. Soon, health experts plan to test the ...
- Chikungunya vaccine: Valneva reports excellent final Phase 1 resultson November 18, 2019 at 5:59 am
Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet medical needs, today announced excellent final Phase 1 results for its single-shot ...
- BRIEF-Valneva Chikungunya Vaccine Phase 1 Successful, Plans Accelerated Phase 3on November 17, 2019 at 10:52 pm
Nov 18 (Reuters) - Valneva SE: * VALNEVA REPORTS EXCELLENT FINAL PHASE 1 RESULTS FOR ITS CHIKUNGUNYA VACCINE CANDIDATE, CONFIRMS PLANS * FINAL PHASE 1 RESULTS UP TO MONTH 13 CONFIRM EXCELLENT ...
- 90% chikungunya cases in over four months: PMC reporton November 15, 2019 at 6:31 pm
PUNE: The cases of chikungunya, a vector-borne ailment like dengue, surged considerably in the city in the past four months. The city had recorded 44 chikungunya cases in August. The number jumped to ...
- Chikungunya outbreak with 82 cases in a monthon November 14, 2019 at 5:13 pm
IPOH: A total of 82 cases of chikungunya were reported within a month at the Batang Padang district, involving areas in Tapah and Bidor, but the outbreak is expected to end in about 10 days. Perak ...
- Sterilizing Mosquitos Could Save Thousands of Liveson November 14, 2019 at 11:38 am
GENEVA - U.N. agencies say early next year, several countries will begin testing a nuclear technique that sterilizes male mosquitoes to control the spread of dengue, Zika and chikungunya to humans.
via Bing News